ALBT closed strong with price and volumeThe chart is looking good. Volume is coming in and the price moved up creating an Alpha Candle. We shall see what it brings.
−0.9064USD
−11.93 MUSD
1.20 MUSD
4.78 M
About Avalon GloboCare Corp.
Sector
Industry
CEO
David K. Jin
Website
Headquarters
Freehold
Founded
2014
ISIN
US05344R2031
FIGI
BBG008648HM7
Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments. The Real Property Operating segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to rental properties. The Medical Related Consulting segment relates to labor and related benefits, travel expenses, and related to consulting services. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ALBT is 0.31 USD — it has increased by 1.91% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Avalon GloboCare Corp. stocks are traded under the ticker ALBT.
Yes, you can track Avalon GloboCare Corp. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ALBT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Avalon GloboCare Corp. stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Avalon GloboCare Corp. EBITDA is −8.20 M USD, and current EBITDA margin is −580.34%. See more stats in Avalon GloboCare Corp. financial statements.